De Novo device
OsteoProbe (OP-100)
Active Life Scientific, Inc. · Bone Indentation Device (QGQ, Class II) · First FDA decision Aug 19, 2021, newest Sep 11, 2025Osteoporosis and fragility fractures
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
De Novo pathway
Device trials
3
Naming "OsteoProbe"
MAUDE reports
0
Brand "OsteoProbe", since 2015
PubMed studies
49
Mentioning "OsteoProbe"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing OsteoProbe (OP-100)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- OsteoProbe (OP-100)510(k)
K250216 · Decided Sep 11, 2025 · 230 days after receipt
Device type: Bone Indentation Device (QGQ) · Orthopedic Surgery
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "OsteoProbe", any status and sponsor, newest update first.
- Utility of Cortical Bone Tissue Properties in the Assessment of Fracture RiskActive, not recruiting
Beth Israel Deaconess Medical CenterAcademic, hospital or other
NCT03076034 · 190 participants (planned) · Start Jan 26, 2015 · Primary completion Aug 8, 2028
Device: Reference Point Indentation · For: Distal Radius Fracture; Osteoporosis; Hip Fractures
Sites: Boston, Massachusetts
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "OsteoProbe", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QGQ
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "OsteoProbe"[tiab]. The summary above synthesizes these.
- Modeling of Osteoprobe indentation on bone.
Idkaidek A, Jasiuk I · J Mech Behav Biomed Mater · 2019Research Support, U.S. Gov't, Non-P.H.S.
- Feasibility and tolerability of bone impact microindentation testing: a cross-sectional, population-based study in Australia.
Rufus-Membere P, Holloway-Kew KL, Diez-Perez A, et al. · BMJ Open · 2018Research Support, Non-U.S. Gov't
- The practicality of using bone impact microindentation in a population-based study of women: A Geelong-Osteoporosis Study.
Rufus-Membere P, Anderson KB, Holloway-Kew KL, et al. · Bone Rep · 2024
- Assessing the inter- and intra-animal variability of in vivo OsteoProbe skeletal measures in untreated dogs.
McNerny EM, Organ JM, Wallace JM, et al. · Bone Rep · 2016
- Safety Outcomes of Impact Microindentation: A Prospective Observational Study in the Netherlands.
Schoeb M, Avci TM, Winter EM, et al. · JBMR Plus · 2023
- Reference Intervals for Bone Impact Microindentation in Healthy Adults: A Multi-Centre International Study.
Rufus-Membere P, Holloway-Kew KL, Diez-Perez A, et al. · Calcif Tissue Int · 2023Multicenter Study, Research Support, N.I.H., Extramural
- Associations between parameters of peripheral quantitative computed tomography and bone material strength index.
Holloway-Kew KL, Rufus-Membere P, Anderson KB, et al. · Bone · 2022Research Support, Non-U.S. Gov't
- Correlation between reference point indentation and mechanical properties of 3D-printed polymers.
Pang S, Jasiuk I · Rev Sci Instrum · 2023
- Impact microindentation assesses subperiosteal bone material properties in humans.
Rokidi S, Bravenboer N, Gamsjaeger S, et al. · Bone · 2020Research Support, N.I.H., Extramural
- Normative Data for Impact Microindentation for Australian Men: Cross-Sectional Data From the Geelong Osteoporosis Study.
Rufus-Membere P, Holloway-Kew KL, Kotowicz MA, et al. · JBMR Plus · 2020
- Intraoperative use of impact microindentation to assess distal radius bone quality.
Lee DH, Reasoner K, Uppuganti S, et al. · Rev Sci Instrum · 2022
- Significant correlation of bone material strength index as measured by the OsteoProbe with Vickers and Rockwell hardness.
Ly FS, Proctor A, Hoffseth K, et al. · Rev Sci Instrum · 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.